Feasibility study of allogeneic mesenchymal stem cell therapy in patients with hypophosphatase

Feasibility study of allogeneic mesenchymal stem cell therapy in patients with hypophosphatasia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1060210038

Enrollment

Registered

2021-10-05

Start date

2021-10-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypophosphatasia Hypophosphatasia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Diagnosed as hypophosphatasia 2) Under 12 years old 3) Have or have been treated with asphotase alpha 4) Written consent of the surrogate has been obtained for participation in this study.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
HLA matching between commartial bone marrow donor database and participant	—

Secondary

Measure	Time frame
HLA matching between donor database of Japan Marrow Donor Program and participant	—

Contacts

Public ContactTakeshi Taketani

Shimane University

ttaketani@med.shimane-u.ac.jp+81-853-20-2220

Outcome results